ICD-10 code for histiocytic sarcoma

The ICD-10-CM code for histiocytic sarcoma is C96.A (Histiocytic sarcoma).

Within C96 (other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue), C96.A is specifically for histiocytic sarcoma. Related codes cover multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis (C96.0), malignant mast cell neoplasm (C96.2), sarcoma of dendritic cells (accessory cells) (C96.4), multifocal and unisystemic Langerhans-cell histiocytosis (C96.5), Unifocal Langerhans-cell histiocytosis (C96.6), malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified (C96.9) and other specified malignant neoplasms of lymphoid, hematopoietic and related tissue (C96.Z).

As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 011 (Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with MCC, relative weight 5.6154), DRG 012 (Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy with CC, relative weight 4.381), DRG 013 (Tracheostomy for Face, Mouth and Neck Diagnoses or Laryngectomy without CC/MCC, relative weight 2.7307), DRG 820 (Lymphoma and Leukemia with Major O.R. Procedures with MCC, relative weight 6.2481), DRG 821 (Lymphoma and Leukemia with Major O.R. Procedures with CC, relative weight 2.2023), DRG 822 (Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC, relative weight 1.1272) and 6 more, in Pre-MDC and MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.